Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions

NCT: NCT06736899 · RECRUITING

NCT IDNCT06736899
StatusRECRUITING
Start Date2025-10-23
Completion2026-12-31

Brief Summary

Clinical research with medical devices indicated in accordance with the CE marking, led by researchers, multicenter, open, prospective, randomized and controlled. Patients are randomized to treatment with a conventional balloon and then a coronary stent or to initial plaque modification with Orbital Atherectomy (OA) and then a coronary stent. To evaluate the efficacy and safety of OA in the adequate treatment with coronary stent of the calcified bifurcation lesion using angiography and optical coherence tomography (OCT).

Frequently Asked Questions

What is Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions?

Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions is a clinical trial registered under NCT06736899. Current status: RECRUITING.

What is the status of NCT06736899?

The current status of NCT06736899 (Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions) is: RECRUITING.

When did Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions start?

Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions started on 2025-10-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.